TQ Course | Clinical Discussions In Glaucoma (Nashville 2022) by Innereactive | Oct 24, 2022 | 2022 Nashville, TQ Courses | 0 comments "*" indicates required fields HiddenClinical Discussions in GlaucomaHiddenDate (Hidden) MM slash DD slash YYYY HiddenEvent Date (Hidden) MM slash DD slash YYYY HiddenEvent 60 days past date (Hidden) MM slash DD slash YYYY HiddenEvent Date Difference (Hidden)1. Which of the following procedures is necessary for the diagnosis of glaucoma?* a. Gonioscopy b. B scan ultrasonography c. Axial length measurement d. Corneal hysteresis 2. Which of the following visual field defects may be expected for a patient with a superior temporal notch in the neuroretinal rim?* a. Enlarged blind spot b. Inferior nasal step c. Superior arcuate scotoma d. No visual field defect is expected 3. According to ICD-10 criteria, what stage of primary open angle glaucoma is described by an inferior arcuate scotoma and superior nasal step in the right eye without defect within the central five degrees of fixation?* a. Indeterminate stage b. Mild stage c. Moderate stage d. Severe stage 4. Megalopapillae is correctly described as:* a. A congenital anomaly where disc area is larger than 2.5mm2 b. Cup to disc ratio greater than 0.5 in the vertical meridian c. A characteristic feature of normal tension glaucoma d. Another term for peripapillary atrophy 5. Which of the following represents an appropriate medication combination for glaucoma therapy (i.e. no duplications of medications or classes)?* a. Cosopt and timolol b. Simbrinza and brimonidine c. Latanoprost and Vyzulta d. Vyzulta and brimonidine 6. Which of the following statements regarding primary open angle glaucoma is true?* a. It is elevated intraocular pressure b. It is a progressive, chronic optic neuropathy c. It is a rare cause of vision loss d. It is characterized by the presence of angle recession 7. What is the preferred method to evaluate the optic disc in the evaluation of glaucoma?* a. Direct ophthalmoscopy b. Optical coherence tomography c. Slit lamp fundus biomicroscopy d. Binocular indirect ophthalmoscopy 8. How does the 24-2C visual field test pattern differ from the 24-2 pattern?* a. There is a greater distance between test points in the 24-2C pattern b. There are an additional 10 paracentral test points in the 24-2C pattern c. The stimulus size is larger in the 24-2C pattern d. There is a wider area of the visual field tested in the 24-2C pattern 9. Which of the following findings is an expected effect of a topical ophthalmic prostaglandin analog?* a. Widening of the palpebral fissure b. Slowed heart rate c. Conjunctival hyperemia d. Corneal verticillate 10. Which of the following minimum IOP that defines ocular hypertension?* a. 15 mm Hg or higher b. 21 mm Hg or higher c. 24 mm Hg or higher d. 30 mm Hg or higher 11. What was the IOP reduction on the Ocular Hypertension Treatment (OHTS) study?* a. 15% b. 20% c. 25% d. 30% 12. What was the IOP reduction on the Early Manifest Glaucoma Trial (EMGT) study?* a. 15% b. 20% c. 25% d. 30% 13. What was the IOP reduction on the Collaborative Normal Tension Glaucoma Study (CNTGS) study?* a. 15% b. 20% c. 25% d. 30% 14. Where on the optic disc is a hemorrhage least likely to occur in glaucoma?* a. Superior temporal b. Inferior temporal c. Nasal d. Inferior 15. Which of the following medications is least helpful in managing neovascular glaucoma?* a. Diamox b. Atropine c. Prednisolone acetate d. Latanoprost 16. Which of the following is considered to be the ultimate treatment for neovascular glaucoma?* a. Anti-VEGF injection b. Pan retinal photocoagulation (PRP) c. Diamox d. Aqueous suppressants 17. The ZAP study examined which surgical intervention?* a. Laser peripheral iridotomy b. Trabecular stenting c. Trabecular bypass procedure d. Suprachoroidal bypass procedure 18. According to the ZAP study, laser intervention reduced the risk of developing angle closure by what percentage?* a. 100% b. 78% c. 60% d. 47% 19. How many untreated eyes in the ZAP study went on to develop actual angle closure of some form?* a. 125 b. 36 c. 7 d. None 20. Which patient may be most likely to have long-term IOP rise after an intravitreal injection?* a. A 75-year-old who has received two intravitreal injections per year for one year b. A 51-year-old who has received 10 intravitreal injections per year for 3 years c. A 67-year-old myope who has received one intravitreal injection d. A 90-year-old who has received five injections in her lifetime Personal InformationName* First Last Email* Phone*OE Tracker # License # Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationHiddenRetake Code Clinical Discussions in Glaucoma | TQ Credit*After 12/23/2022, pricing will increase to $30. Price: (Past 60 Days) Clinical Discussions in Glaucoma | TQ CreditThis course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: (Past 60 Days) Retake Discount Price: Payment MethodPayPal Checkout American ExpressDiscoverMasterCardVisaSupported Credit Cards: American Express, Discover, MasterCard, Visa Card Number Expiration Date Security Code Cardholder Name HiddenCourse Information (HIDDEN)HiddenCourse Name (HIDDEN) HiddenRetake Code (HIDDEN) HiddenQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/) HiddenCE Hours (HIDDEN) Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
